Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
阿特珠单抗/贝伐珠单抗治疗进展后晚期肝细胞癌的二线治疗模式和结果
期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2024.101232
Wu, Meng; Fulgenzi, Claudia A M; D'Alessio, Antonio; Cortellini, Alessio; Celsa, Ciro; Manfredi, Giulia F; Stefanini, Bernardo; Wu, Y Linda; Huang, Yi-Hsiang; Saeed, Anwaar; Pirozzi, Angelo; Pressiani, Tiziana; Rimassa, Lorenza; Schoenlein, Martin; Schulze, Kornelius; von Felden, Johann; Mohamed, Yehia; Kaseb, Ahmed O; Vogel, Arndt; Roehlen, Natascha; Silletta, Marianna; Nishida, Naoshi; Kudo, Masatoshi; Vivaldi, Caterina; Balcar, Lorenz; Scheiner, Bernhard; Pinter, Matthias; Singal, Amit G; Glover, Joshua; Ulahannan, Susanna; Foerster, Fredrich; Weinmann, Arndt; Galle, Peter R; Parikh, Neehar D; Hsu, Wei-Fan; Parisi, Alessandro; Chon, Hong Jae; Pinato, David J; Ang, Celina